Haemonetics
S&P 400
$102.69
+1.61%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Comfortable interest cover: operating profit covers interest about 8.1 times.
- Return on equity is moderate at 11.6%.
- Net profit margin is 7.3%.
- Current assets comfortably cover current liabilities (current ratio 2.95).
!Watch-points
- Higher leverage: debt-to-equity of 1.46 is above 1.
- Return on capital employed is on the lower side at 7.5%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Piotroski F-ScoreModerate
6 / 8
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 8 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$4.67B
Current Price$ 102.69
High / Low$ 109.57 / 47.32
Stock P/E49.6087
Book Value$ 18.32
Dividend Yield0%
ROCE7.53%
ROE11.62%
Debt to Equity1.46
Current Ratio2.95
P/B Ratio5.57825
EPS$ 2.05
Debt$1.22B
PAT Margin7.29%
Cash PAT$209.03M
ICR8.12